| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cardiac Imaging |
1 From the Department of Radiology (C.J.F., S.M.S., J.P.F.) and Division of Cardiology (R.O.B.), Northwestern University Medical School, Chicago, Ill. Received April 5, 2002; revision requested June 14; final revision received October 11; accepted October 14. Address correspondence to J.P.F., Department of Radiological Sciences, UCLA Medical Center, 10833 LeConte Ave, Los Angeles, CA 90095-1721 (e-mail: pfinn@mednet.ucla.edu).
PURPOSE: To build a database of arm-to-aorta circulation times for contrast enhancement and to determine if measured transit times can help in discrimination between patients with and patients without heart disease.
MATERIALS AND METHODS: Findings at test-bolus examinations performed before acquisition of contrast material–enhanced magnetic resonance (MR) angiographic images of the head and neck were retrospectively reviewed. The times from test-bolus injection to first and peak enhancement in regions of interest were recorded in 77 patients with coronary artery disease, left ventricular hypertrophy, and/or impaired left ventricular function and 33 control subjects. Transit times in patients and control subjects were compared with Student t test. Linear regression was performed to measure the correlation coefficient.
RESULTS: Transit times in patients with heart disease, including those with a normal ejection fraction, were significantly prolonged compared with those in control subjects (P < .05). Mean time to peak enhancement in the carotid artery bifurcation was 16.6 seconds ± 1.9 (SD) and 20.8 seconds ± 3.9 in control subjects and patients, respectively. Threshold value of 18 seconds for time to peak signal intensity in the carotid artery bifurcation provided highest combination of sensitivity and specificity. All (11 of 11) patients with an ejection fraction less than 40% and only three (9%) of 33 control subjects had circulation times greater than this threshold. No significant correlation was found between transit times and age, sex, weight, and height.
CONCLUSION: Transit times measured with MR imaging may help in discrimination between patients with and patients without heart disease, independently of other cardiac functional parameters.
© RSNA, 2003
Index terms: Heart, diseases, 51.72, 51.76, 51.78 • Magnetic resonance (MR), contrast enhancement, 51.12142, 51.12143 • Magnetic resonance (MR), vascular studies, 51.12142 • Pulmonary arteries, MR, 944.12942, 944.12943
This article has been cited by other articles:
|
|
 |
|
  L. L. Chu, B. N. Joe, A. C. A. Westphalen, E. M. Webb, F. V. Coakley, and B. M. Yeh Patient-specific Time to Peak Abdominal Organ Enhancement Varies with Time to Peak Aortic Enhancement at MR Imaging Radiology, December 1, 2007; 245(3): 779 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fenchel, R. Saleh, H. Dinh, M. H. Lee, K. Nael, M. Krishnam, S. G. Ruehm, S. Miller, J. Child, and J. P. Finn Juvenile and Adult Congenital Heart Disease: Time-resolved 3D Contrast-enhanced MR Angiography Radiology, August 1, 2007; 244(2): 399 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ashani and S. Pistinner Estimation of the Upper Limit of Human Butyrylcholinesterase Dose Required for Protection against Organophosphates Toxicity: a Mathematically Based Toxicokinetic Model Toxicol. Sci., February 1, 2004; 77(2): 358 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Shors, W. G. Cotts, B. Pavlovic-Surjancev, C. J. Francois, M. Gheorghiade, and J. P. Finn Heart Failure: Evaluation of Cardiopulmonary Transit Times with Time-resolved MR Angiography Radiology, December 1, 2003; 229(3): 743 - 748. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
